Inotiv, Inc. (NOTV) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Inotiv Reports Third Quarter Financial Results for Fiscal 2023 and Provides Business Update
August 10, 2023 4:08 PM EDTWEST LAFAYETTE, Ind., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the Company, We, Our or Inotiv), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (Q3 FY 2023) and nine months (YTD FY 2023) ended June 30, 2023.
Financial Highlights
Q3 FY 2023 Highlights
Revenue was $157.5 million in Q3 FY 2023 as compared to $172.7 million during the three months... More